Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GHNYSE:HIMSNASDAQ:OPCHNASDAQ:PRVA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGHGuardant Health$46.46-0.6%$44.20$15.81▼$50.89$5.73B1.52.14 million shs1.30 million shsHIMSHims & Hers Health$37.06-0.9%$39.66$11.20▼$72.98$8.23B1.3713.93 million shs17.49 million shsOPCHOption Care Health$35.18+1.4%$32.11$21.39▼$35.44$5.78B1.331.64 million shs1.43 million shsPRVAPrivia Health Group$22.75-4.9%$23.75$15.92▼$26.04$2.74B0.85756,060 shs1.12 million shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGHGuardant Health+1.39%+8.95%+9.03%+48.05%+170.96%HIMSHims & Hers Health+7.48%+7.75%-23.89%+32.74%+128.82%OPCHOption Care Health+0.38%+2.42%+8.47%+52.17%+6.21%PRVAPrivia Health Group+2.49%+2.93%-2.45%+20.20%+21.98%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGHGuardant Health3.8009 of 5 stars2.52.00.04.43.32.50.6HIMSHims & Hers Health2.2444 of 5 stars2.12.00.00.02.13.31.9OPCHOption Care Health4.2298 of 5 stars2.45.00.04.23.62.50.6PRVAPrivia Health Group3.9121 of 5 stars3.54.00.00.03.32.51.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGHGuardant Health 3.00Buy$48.404.18% UpsideHIMSHims & Hers Health 2.27Hold$37.310.67% UpsideOPCHOption Care Health 2.75Moderate Buy$33.00-6.20% DownsidePRVAPrivia Health Group 3.06Buy$26.6717.22% UpsideCurrent Analyst Ratings BreakdownLatest PRVA, HIMS, GH, and OPCH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/21/2025PRVAPrivia Health GroupNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$30.00 ➝ $30.003/18/2025HIMSHims & Hers HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderperform ➝ Underperform$21.00 ➝ $22.003/6/2025GHGuardant HealthMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$42.00 ➝ $52.003/6/2025HIMSHims & Hers HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderperform ➝ Underperform$21.00 ➝ $21.003/6/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell$27.00 ➝ $27.003/6/2025OPCHOption Care HealthJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$40.00 ➝ $41.002/28/2025PRVAPrivia Health GroupJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$29.002/28/2025PRVAPrivia Health GroupCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$29.00 ➝ $30.002/28/2025PRVAPrivia Health GroupPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$25.00 ➝ $40.002/28/2025PRVAPrivia Health GroupNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$25.00 ➝ $30.002/27/2025OPCHOption Care HealthBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$33.00 ➝ $38.00(Data available from 3/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGHGuardant Health$739.02M7.76N/AN/A$1.34 per share34.67HIMSHims & Hers Health$1.48B5.58N/AN/A$1.61 per share23.02OPCHOption Care Health$5.00B1.16$2.05 per share17.19$8.03 per share4.38PRVAPrivia Health Group$1.74B1.58$0.23 per share98.24$5.14 per share4.43Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGHGuardant Health-$479.45M-$3.56N/AN/AN/A-59.05%-19,157.20%-25.96%5/8/2025 (Estimated)HIMSHims & Hers Health-$23.55M$0.5484.2371.27N/A8.19%10.97%8.29%5/5/2025 (Estimated)OPCHOption Care Health$267.09M$1.2229.5627.922.304.37%15.30%6.57%4/29/2025 (Estimated)PRVAPrivia Health Group$23.08M$0.11227.5284.263.470.75%2.02%1.21%5/8/2025 (Estimated)Latest PRVA, HIMS, GH, and OPCH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/22/2025N/AOPCHOption Care Health$0.36N/AN/AN/A$1.26 billionN/A2/24/2025Q4 2024HIMSHims & Hers Health$0.09$0.11+$0.02$0.11$494.56 million$481.14 million2/20/2025Q4 2024GHGuardant Health-$0.75-$0.90-$0.15-$0.90$192.50 million$201.81 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGHGuardant HealthN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/APRVAPrivia Health GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGHGuardant HealthN/A6.225.85HIMSHims & Hers HealthN/A2.141.82OPCHOption Care Health0.771.731.32PRVAPrivia Health GroupN/A1.781.78Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGHGuardant Health92.60%HIMSHims & Hers Health63.52%OPCHOption Care Health98.05%PRVAPrivia Health Group94.48%Insider OwnershipCompanyInsider OwnershipGHGuardant Health5.50%HIMSHims & Hers Health17.71%OPCHOption Care Health0.64%PRVAPrivia Health Group14.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGHGuardant Health1,790123.42 million116.76 millionNot OptionableHIMSHims & Hers Health650222.17 million179.79 millionOptionableOPCHOption Care Health5,600164.24 million169.09 millionOptionablePRVAPrivia Health Group810120.51 million102.96 millionOptionablePRVA, HIMS, GH, and OPCH HeadlinesRecent News About These CompaniesAdvantage Alpha Capital Partners LP Takes $2.25 Million Position in Privia Health Group, Inc. (NASDAQ:PRVA)March 25 at 6:06 AM | marketbeat.comProficio Capital Partners LLC Takes $464,000 Position in Privia Health Group, Inc. (NASDAQ:PRVA)March 25 at 3:19 AM | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) Receives Average Rating of "Buy" from BrokeragesMarch 24 at 2:07 AM | marketbeat.comPrivia Health Group's (PRVA) "Buy" Rating Reiterated at Needham & Company LLCMarch 23 at 2:19 AM | americanbankingnews.comNeedham Reaffirms Their Buy Rating on Privia Health Group (PRVA)March 22 at 10:13 PM | markets.businessinsider.comPrivia Health Group's (PRVA) Buy Rating Reiterated at Needham & Company LLCMarch 22 at 8:46 AM | marketbeat.com5PRVA : Breaking Down Privia Health Gr: 10 Analysts Share Their ViewsMarch 21, 2025 | benzinga.comCharles Schwab Investment Management Inc. Has $22.17 Million Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA)March 19, 2025 | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) Shares Bought by Victory Capital Management Inc.March 16, 2025 | marketbeat.comProficio Capital Partners LLC Invests $464,000 in Privia Health Group, Inc. (NASDAQ:PRVA)March 11, 2025 | marketbeat.comBank of New York Mellon Corp Sells 227,357 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)March 6, 2025 | marketbeat.comPrivia Health Group (PRVA) Gets a Buy from Stifel NicolausMarch 4, 2025 | markets.businessinsider.comLeerink Partnrs Has Pessimistic View of PRVA Q1 EarningsMarch 3, 2025 | marketbeat.comCanaccord Genuity Group Boosts Privia Health Group (NASDAQ:PRVA) Price Target to $30.00March 1, 2025 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Price Target Raised to $40.00 at Piper SandlerMarch 1, 2025 | marketbeat.comNeedham & Company LLC Issues Positive Forecast for Privia Health Group (NASDAQ:PRVA) Stock PriceMarch 1, 2025 | marketbeat.comVersor Investments LP Acquires New Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)March 1, 2025 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPSFebruary 28, 2025 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Reaches New 1-Year High - Here's What HappenedFebruary 28, 2025 | marketbeat.comPrivia Health price target raised to $30 from $29 at CanaccordFebruary 28, 2025 | markets.businessinsider.comPrivia Health Group, Inc. (NASDAQ:PRVA) Q4 2024 Earnings Call TranscriptFebruary 28, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Aviation Stock Climbs as Midnight eVTOL Nears RealityBy Jeffrey Neal Johnson | March 10, 2025View Archer Aviation Stock Climbs as Midnight eVTOL Nears RealityBigBear.ai: Is It Opportunity Knocking or a Trap Door?By Jeffrey Neal Johnson | February 25, 2025View BigBear.ai: Is It Opportunity Knocking or a Trap Door?NVIDIA Stock Remains Stunningly Undervalued—Here’s WhyBy Thomas Hughes | March 11, 2025View NVIDIA Stock Remains Stunningly Undervalued—Here’s WhyFinding Hidden Gems: Unconventional Penny Stock InvestingBy Dan Schmidt | February 24, 2025View Finding Hidden Gems: Unconventional Penny Stock InvestingNebius Slides Post-Earnings: A Long-Term Buy Opportunity?By Ryan Hasson | February 25, 2025View Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?PRVA, HIMS, GH, and OPCH Company DescriptionsGuardant Health NASDAQ:GH$46.46 -0.28 (-0.60%) Closing price 04:00 PM EasternExtended Trading$46.00 -0.46 (-0.99%) As of 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Hims & Hers Health NYSE:HIMS$37.06 -0.35 (-0.94%) Closing price 03:58 PM EasternExtended Trading$36.94 -0.12 (-0.32%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.Option Care Health NASDAQ:OPCH$35.18 +0.47 (+1.35%) Closing price 04:00 PM EasternExtended Trading$35.18 +0.01 (+0.01%) As of 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.Privia Health Group NASDAQ:PRVA$22.75 -1.17 (-4.89%) Closing price 04:00 PM EasternExtended Trading$22.96 +0.21 (+0.92%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Insiders Sell: This Is What It Means for the Market Oklo’s Stock Price Meltdown Is an Opportunity to Buy Top Dividend Stocks With Over 10 Years of Hikes—and Room to Grow Quantum Gamble? Is IonQ's Stock an Opportunity or a Mirage? Will CrowdStrike's FedRAMP Authorization Move CRWD Stock? Top 3 Insider Stock Buys in March—Are They Still Good in April? Taiwan Semiconductor Attracts Big Money on NVIDIA Chip Growth D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
